PubMed Health⌕ Search

Biomedical subjects

U J Schmidt

Publications and source records attributed to U J Schmidt.

At least 19 recordsLinked to original sources

[Causes of death in the aged and their significance for surgery].

Based on an analysis of the most frequent causes of death in old age, i.e. cardiovascular diseases, pulmonary diseases and neoplasia, a number of consequences can be drawn from the surgical point of view. It is undoubtedly difficult still to find ways and means of prolonging the life of an elderly person suffering from an acute illness in the presence of degenerative cardiac and vascular diseases. Yet we feel, that interdisciplinary cooperation with a high degree of responsibility between surgeons, internal specialists and anesthetists still offers possibilities to achieve this aim. All efforts should be focused on relieving cardiovascular and respiratory insufficiency. Furthermore, we regard surgery at the time of choice as an opportunity to reduce mortality rates which are greatly influenced by complications of diseases requiring an operation. The success of an operation depends on precise surgical work and swift acting. It should be a moral duty not only of the medical profession, but also of young people to treat the elderly with esteem, respect, love and care.

Age Factors↗

[On the effect of biologically active substances (experimental studies) (author's transl)].

The influence of prolonged Procaine and Turigeran therapy on the cellular kinetics of the mucous membrane of the liver and small intestine has been studied by means of 3H-thymidine histo-autoradiography of a total of 240 12-month-old male Wistar rats. The following observations have been made: 1. The pool of DNA-synthesizing liver parenchyma cells and Kupffer's cells in the treated animals is clearly increased compared with that of the untreated controls. There is no difference between the rats treated with Procaine and those treated with Turigeran. 2. Nor does the cellular kinetics of the mucosa of the small intestine exhibit any differences between the animals treated with Procaine and those treated with Turigeran. Since, on the other hand, significant differences appear between the treated animals and the untreated controls regarding all characteristics of cellular kinetics, this effect is solely attributable to Procaine. 3. The various phases of the cellular cycle are prolonged in the treated animals, resulting in an overall delay in the generative cycle. 4. A reduced speed of migration of the cells in the region of crypts and villi finally results in the fact that in spite of the reduced rates of proliferation a greater number of labelled cells can be observed in the crypts of the treated animals (labelling index). 5. The unmitigated effect of Procaine is discernible for at least two weeks after the discontinuation of the treatment.

Animals↗

Effect of dimethylaminomethylendiphosphonate on the immobilisation osteoporosis in rats.

The influence of the immobilization on the bone by the resection of the N. ischiadicus has been examined in rats, 130--150 g and 400 g of weight. The simultaneous administration of dimethylaminomethylendiphosphonate uses to lower the differences in respect to osteodissimilation between the immobilized and not immobilized extremity, caused by immobilization.

Animals↗

[Long-term therapy with calcitonin in Paget's diseases (author's transl)].

16 patients with a Paget's disease at the age of 51--80 years were treated by synthetic salmon calcitonine in a dosis of 20 mcg (80 MRCU/die). 14 patients could be observed for a longer time. In all cases there was a statically significant decrease of the increased alkaline serum phosphatase. The excretion of hydroxyproline in the collected urine had a decreasing tendency. Other laboratory parameters as calcium, phosphatase and acid phosphatase in the serum and the excretion of calcium and phosphate in the urine were not significant influenced by therapy. The patients felt subjective a clear improvement of the bone pains. After a six month-treatment the dosis was reduced (each 2--7 days 20 mcg salmon calcitonin sc). There was observed a rebehaviour of the subjective symptoms and an increase of the alkaline serum phosphatase, which did not reach the unitial values before the beginning of treatment. Calcitonine is an effective substance for the treatment of an active Paget's disease.

Acid Phosphatase↗

[On the treatment of the osteodystrophia deformans (Paget's disease) with synthetic salmon calcitonin (author's transl)].

Sixteen patients with Paget's disease of bone aged from 51 to 80 years was treated daily with 20 micrograms (equivalent to 80 MRCU) synthetic salmon calcitonin. Fourteen patients was observed on a long time. In all cases was observed significant reductions in increased serum alkaline phosphatase. The urinary hydroxyproline excretion was also decreased. Other laboratory dates as serum calcium, serum phosphorus, serum acide phosphatase, urinary calcium and phosphorus excretion was not significantly influenced by the therapy. The treatment produced a clear remission of pain. After treatment of 6 months the dose was reduced (2 or 3 injections subcutaneously of 20 micrograms salmon calcitonin weekly). There was observed a recurrence of pain and an increase of serum alkaline phosphatase, but not until the pretreatment values. These results confirm the effectiveness of calcitonin treatment in Paget's disease of bone.

Aged↗